DAPK1 and diffuse large B-cell lymphoma: Our results confirm the potential of DAPK1 methylation as a prognostic marker in DLBCL treated with R-CHOP, as it was associated with shorter overall survival (p=0.017) and disease-specific survival (p=0.023).